| |
| |
|
| Insider
Information: |
Sigal Elliot |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
148,221 |
|
|
Indirect Shares
|
78,638 |
|
|
| Direct
Value |
$6,603,246 |
|
|
|
Indirect Value
|
$5,681,525 |
|
|
| Total
Shares |
226,859 |
|
|
| Total
Value |
$12,284,771 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2009-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2015-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,214 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
officerTitle |
• – – |
2003-08-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,219) |
75,024 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
officerTitle |
• – – |
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
100,024 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2004-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
8,056 |
107,024 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2004-08-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(939) |
106,085 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2005-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,150) |
104,935 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2005-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,038) |
101,897 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2005-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,250 |
119,147 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
• – – |
2005-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
169,147 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
• – – |
2007-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,150) |
178,958 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
• – – |
2007-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,038) |
175,920 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2007-09-10 |
4/A |
D |
$0.00 |
$0 |
D/D |
(3,882) |
172,271 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2007-09-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,871) |
172,282 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2009-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
28,700 |
182,579 |
0 |
- |
|
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2009-12-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,039 |
1,039 |
0 |
- |
|
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2009-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,950 |
12,950 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2009-12-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,647) |
1,389 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2009-12-23 |
4 |
S |
$0.00 |
$0 |
D/D |
(12,594) |
153,040 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
72,043 |
223,044 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2010-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(33,393) |
189,651 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,875 |
196,526 |
0 |
- |
|
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2011-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,160 |
15,110 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,000 |
250,496 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• • – |
2011-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,096) |
200,400 |
0 |
- |
|
133 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
